Karyopharm Therapeutics | KPTI - Selling And Administration Expenses


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Karyopharm Therapeutics

Karyopharm Therapeutics reported $35.91M in Selling and Administration Expenses for its fiscal quarter ending in March of 2023.


Selling And Administration Expenses Change
AbbVie ABBV:US USD 3B 217M
Abbott ABT:US USD 2.75B 83M
Amgen AMGN:US USD 1.26B 210M
AstraZeneca AZN:LN USD 3.2B 331M
Avrobio Inc AVRO:US USD 7.89M 767K
BioCryst Pharmaceuticals BCRX:US USD 47.87M 2.29M
Bristol-Myers Squibb BMY:US USD 1.76B 504M
Eli Lilly LLY:US USD 1.75B 106M
Enanta Pharmaceuticals ENTA:US USD 13.78M 1.08M
GlaxoSmithKline GSK:LN GBP 2.06B 370M
Incyte Corp INCY:US USD 315.61M 42.79M
J&J JNJ:US USD 6.14B 374M
Karyopharm Therapeutics KPTI:US USD 35.91M 1.26M
MacroGenics MGNX:US USD 13.53M 145K
Merck & Co MRK:US USD 2.46B 209M
Mirati Therapeutics MRTX:US USD 73.49M 2.67M
Nektar Therapeutics NKTR:US USD 21.08M 858K
Novartis NOVN:VX USD 3.4B 298M
Novartis NVS:US USD 3.4B 298M
Pfizer PFE:US USD 3.49B 1.39B
Regeneron Pharmaceuticals REGN:US USD 601.1M 59.4M
Roche Holding ROG:VX 6.48B 834M
Sangamo BioSciences SGMO:US USD 18.14M 1.69M
Takeda 4502:JP JPY 254.8B 7.5B
TG Therapeutics TGTX:US USD 28.07M 5.56M
Ultragenyx Pharmaceutical RARE:US USD 76.65M 3.8M
Xencor XNCR:US USD 13.95M 1.2M